Back to JONES FINANCIAL COMPANIES LLLP JONES FINANCIAL COMPANIES LLLP

NKTRNKTR

3 quarters

Position history for JONES FINANCIAL COMPANIES LLLPJONES FINANCIAL COMPANIES LLLP's holdings in NEKTAR THERAPEUTICS

As of its Q1 2025 13F, Jones Financial Companies held 905 shares of NKTR (Nektar Therapeutics), worth $668. Jones Financial Companies' 13F filings listed NKTR from Q4 2024 to Q1 2025, 2 quarterly filings.

Final Value

$0

Final Shares

0

Total Value Change

-$372

Total Shares Change

-400

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q2
Latest
Exited
0
-100.0%
$00.0%$25.84
0
2025-Q1
Increased
905
+126.3%
$6680.0%$10.20
12
2024-Q4
New
400
—
$3720.0%$13.95
17

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used